Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study

AIMS: Hypoxia‐inducible factor‐prolyl hydroxylase (HIF‐PH) inhibitors have been developed for the treatment of renal anaemia; however, no study has evaluated the safety and efficacy of HIF‐PH inhibitors in patients with heart failure (HF). This study was designed to evaluate the safety and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Iso, Takashi, Matsue, Yuya, Mizukami, Akira, Tokano, Takashi, Isoda, Kikuo, Suwa, Satoru, Miyauchi, Katsumi, Yanagisawa, Naotake, Okumura, Yasuo, Minamino, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773652/
https://www.ncbi.nlm.nih.gov/pubmed/35983622
http://dx.doi.org/10.1002/ehf2.14109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773652/
https://www.ncbi.nlm.nih.gov/pubmed/35983622
http://dx.doi.org/10.1002/ehf2.14109

Ejemplares similares